Two Phase 2 Multiple Ascending–Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer’s Disease
Year: 2016
Type: article
Study design: Clinical Trial
Source: Journal of Alzheimer s Disease
DOI: 10.3233/jad-150376
Authors: Florence Pasquier, Carl Sadowsky, Ann Holstein, Ghislaine Le Prince Leterme, Yahong Peng, Nicholas Jackson, Nick C. Fox, Nzeera Ketter, Enchi Liu, J. Michael Ryan, for the ACC-001 (QS-21) Study Team
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2289661106
